Osimertinib for NSCLC With EGFR Exon 20 Insertion Mutation
Clinical trial NCT03414814 · COMPLETED
Trial details
- NCT number
- NCT03414814
- Sponsor
- Seoul National University Hospital
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-01-04
- Primary completion
- 2021-08-03
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.